Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association

This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman's risk of developing cardiovascular disease...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Circulation (New York, N.Y.) Ročník 143; číslo 18; s. e902
Hlavní autoři:	Parikh, Nisha I, Gonzalez, Juan M, Anderson, Cheryl A M, Judd, Suzanne E, Rexrode, Kathryn M, Hlatky, Mark A, Gunderson, Erica P, Stuart, Jennifer J, Vaidya, Dhananjay
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 04.05.2021
Témata:	American Heart Association - organization & administration Cardiovascular Diseases - prevention & control Female Humans Pregnancy Pregnancy Outcome - epidemiology Risk Factors United States United States primary prevention risk factors pregnancy complications cardiovascular diseases pregnancy AHA Scientific Statements
ISSN:	1524-4539, 1524-4539
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman's risk of developing cardiovascular disease (CVD) risk factors and of developing subsequent CVD (including fatal and nonfatal coronary heart disease, stroke, peripheral vascular disease, and heart failure). This statement highlights the importance of recognizing APOs when CVD risk is evaluated in women, although their value in reclassifying risk may not be established. A history of APOs is a prompt for more vigorous primordial prevention of CVD risk factors and primary prevention of CVD. Adopting a heart-healthy diet and increasing physical activity among women with APOs, starting in the postpartum setting and continuing across the life span, are important lifestyle interventions to decrease CVD risk. Lactation and breastfeeding may lower a woman's later cardiometabolic risk. Black and Asian women experience a higher proportion APOs, with more severe clinical presentation and worse outcomes, than White women. More studies on APOs and CVD in non-White women are needed to better understand and address these health disparities. Future studies of aspirin, statins, and metformin may better inform our recommendations for pharmacotherapy in primary CVD prevention among women who have had an APO. Several opportunities exist for health care systems to improve transitions of care for women with APOs and to implement strategies to reduce their long-term CVD risk. One proposed strategy includes incorporation of the concept of a fourth trimester into clinical recommendations and health care policy.
AbstractList	This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman's risk of developing cardiovascular disease (CVD) risk factors and of developing subsequent CVD (including fatal and nonfatal coronary heart disease, stroke, peripheral vascular disease, and heart failure). This statement highlights the importance of recognizing APOs when CVD risk is evaluated in women, although their value in reclassifying risk may not be established. A history of APOs is a prompt for more vigorous primordial prevention of CVD risk factors and primary prevention of CVD. Adopting a heart-healthy diet and increasing physical activity among women with APOs, starting in the postpartum setting and continuing across the life span, are important lifestyle interventions to decrease CVD risk. Lactation and breastfeeding may lower a woman's later cardiometabolic risk. Black and Asian women experience a higher proportion APOs, with more severe clinical presentation and worse outcomes, than White women. More studies on APOs and CVD in non-White women are needed to better understand and address these health disparities. Future studies of aspirin, statins, and metformin may better inform our recommendations for pharmacotherapy in primary CVD prevention among women who have had an APO. Several opportunities exist for health care systems to improve transitions of care for women with APOs and to implement strategies to reduce their long-term CVD risk. One proposed strategy includes incorporation of the concept of a fourth trimester into clinical recommendations and health care policy.This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman's risk of developing cardiovascular disease (CVD) risk factors and of developing subsequent CVD (including fatal and nonfatal coronary heart disease, stroke, peripheral vascular disease, and heart failure). This statement highlights the importance of recognizing APOs when CVD risk is evaluated in women, although their value in reclassifying risk may not be established. A history of APOs is a prompt for more vigorous primordial prevention of CVD risk factors and primary prevention of CVD. Adopting a heart-healthy diet and increasing physical activity among women with APOs, starting in the postpartum setting and continuing across the life span, are important lifestyle interventions to decrease CVD risk. Lactation and breastfeeding may lower a woman's later cardiometabolic risk. Black and Asian women experience a higher proportion APOs, with more severe clinical presentation and worse outcomes, than White women. More studies on APOs and CVD in non-White women are needed to better understand and address these health disparities. Future studies of aspirin, statins, and metformin may better inform our recommendations for pharmacotherapy in primary CVD prevention among women who have had an APO. Several opportunities exist for health care systems to improve transitions of care for women with APOs and to implement strategies to reduce their long-term CVD risk. One proposed strategy includes incorporation of the concept of a fourth trimester into clinical recommendations and health care policy. This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for-gestational-age delivery, placental abruption, and pregnancy loss increase a woman's risk of developing cardiovascular disease (CVD) risk factors and of developing subsequent CVD (including fatal and nonfatal coronary heart disease, stroke, peripheral vascular disease, and heart failure). This statement highlights the importance of recognizing APOs when CVD risk is evaluated in women, although their value in reclassifying risk may not be established. A history of APOs is a prompt for more vigorous primordial prevention of CVD risk factors and primary prevention of CVD. Adopting a heart-healthy diet and increasing physical activity among women with APOs, starting in the postpartum setting and continuing across the life span, are important lifestyle interventions to decrease CVD risk. Lactation and breastfeeding may lower a woman's later cardiometabolic risk. Black and Asian women experience a higher proportion APOs, with more severe clinical presentation and worse outcomes, than White women. More studies on APOs and CVD in non-White women are needed to better understand and address these health disparities. Future studies of aspirin, statins, and metformin may better inform our recommendations for pharmacotherapy in primary CVD prevention among women who have had an APO. Several opportunities exist for health care systems to improve transitions of care for women with APOs and to implement strategies to reduce their long-term CVD risk. One proposed strategy includes incorporation of the concept of a fourth trimester into clinical recommendations and health care policy.
Author	Judd, Suzanne E Stuart, Jennifer J Vaidya, Dhananjay Hlatky, Mark A Gonzalez, Juan M Gunderson, Erica P Rexrode, Kathryn M Parikh, Nisha I Anderson, Cheryl A M
Author_xml	– sequence: 1 givenname: Nisha I surname: Parikh fullname: Parikh, Nisha I – sequence: 2 givenname: Juan M surname: Gonzalez fullname: Gonzalez, Juan M – sequence: 3 givenname: Cheryl A M surname: Anderson fullname: Anderson, Cheryl A M – sequence: 4 givenname: Suzanne E surname: Judd fullname: Judd, Suzanne E – sequence: 5 givenname: Kathryn M surname: Rexrode fullname: Rexrode, Kathryn M – sequence: 6 givenname: Mark A surname: Hlatky fullname: Hlatky, Mark A – sequence: 7 givenname: Erica P surname: Gunderson fullname: Gunderson, Erica P – sequence: 8 givenname: Jennifer J surname: Stuart fullname: Stuart, Jennifer J – sequence: 9 givenname: Dhananjay surname: Vaidya fullname: Vaidya, Dhananjay
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33779213$$D View this record in MEDLINE/PubMed
BookMark	eNp1UE1PGzEQtSpQA7T_oKrm2EvAXq_XWW6rtHxISEFA1GM0tWdbt1k7tb2R-G38ORwBUi7MZUZP70PzjtmBD54Y-yL4qRCNOJtf353y_Wkb8YEdCVXV01rJ9mDvnrDjlP4WTiO1-sgmUmrdVkIesafObikmgttIvz168wiLMZswUAL0FuYYrQtbTGZcY4TvLhEW9p1L_85h6d3_kWCx2YSYR--yK6o-xPdUJWNLPrvgwXn4WUL8OXRwb9wO7Z2B-4yZCpzhIoYB8h-CbqDoDHq4IowZupSCcbgz-cQOe1wn-vy6T9jy4sfD_Gp6s7i8nnc3U1OLmZrWgnqrtVVkW5xZJQXqlrg2gsvK1lxoqrUyvbS15hK1bniPleyFrJqejKlO2LcX300M5d-UV4NLhtZr9BTGtKoUbxSflWoL9esrdfw1kF1tohswPq7eCq-eAQFGiLI
CitedBy_id	crossref_primary_10_1016_j_rec_2025_01_005 crossref_primary_10_1016_j_neubiorev_2021_11_029 crossref_primary_10_1177_17455057241247748 crossref_primary_10_1001_jamanetworkopen_2024_10279 crossref_primary_10_1007_s11906_022_01172_x crossref_primary_10_1161_CIRCOUTCOMES_124_011217 crossref_primary_10_1161_JAHA_123_032973 crossref_primary_10_1097_AOG_0000000000005048 crossref_primary_10_1155_2022_1111438 crossref_primary_10_12688_f1000research_73112_2 crossref_primary_10_1093_ajh_hpad090 crossref_primary_10_12688_f1000research_73112_1 crossref_primary_10_1093_eurjpc_zwad347 crossref_primary_10_1212_CON_0000000000001078 crossref_primary_10_1186_s12916_022_02711_8 crossref_primary_10_1016_j_ajog_2022_06_038 crossref_primary_10_1016_j_amjmed_2022_04_002 crossref_primary_10_1089_jwh_2023_0032 crossref_primary_10_1093_ajh_hpaf033 crossref_primary_10_1016_j_diabres_2023_110470 crossref_primary_10_1016_j_taap_2024_116833 crossref_primary_10_1097_MOL_0000000000000907 crossref_primary_10_1007_s11883_024_01273_9 crossref_primary_10_1007_s10995_023_03725_1 crossref_primary_10_1016_j_jacadv_2023_100377 crossref_primary_10_1016_j_hipert_2022_09_002 crossref_primary_10_1007_s11883_022_01069_9 crossref_primary_10_1016_j_ajpc_2022_100342 crossref_primary_10_1016_j_midw_2024_104270 crossref_primary_10_1007_s12170_022_00703_0 crossref_primary_10_3389_fpubh_2023_1071706 crossref_primary_10_1007_s13669_023_00351_0 crossref_primary_10_1016_j_ijcchd_2021_100236 crossref_primary_10_1161_JAHA_123_030560 crossref_primary_10_3390_diagnostics12092221 crossref_primary_10_1016_j_cpcardiol_2024_102698 crossref_primary_10_3390_ijms26052320 crossref_primary_10_1016_j_cpcardiol_2024_102695 crossref_primary_10_1111_ppe_13055 crossref_primary_10_1001_jama_2022_24093 crossref_primary_10_1161_CIRCULATIONAHA_121_058311 crossref_primary_10_1210_clinem_dgae655 crossref_primary_10_1161_JAHA_121_021733 crossref_primary_10_1055_a_2416_5974 crossref_primary_10_1007_s41347_025_00529_8 crossref_primary_10_1002_alz_70610 crossref_primary_10_1038_s41574_024_01072_x crossref_primary_10_1161_JAHA_124_035391 crossref_primary_10_1507_endocrj_EJ25_0031 crossref_primary_10_1111_mcn_13501 crossref_primary_10_1186_s12916_024_03680_w crossref_primary_10_1161_HYPERTENSIONAHA_124_22857 crossref_primary_10_4103_heartviews_heartviews_102_22 crossref_primary_10_1161_JAHA_121_024443 crossref_primary_10_1016_j_ajog_2023_04_006 crossref_primary_10_1038_s41598_025_03652_x crossref_primary_10_1111_obr_13967 crossref_primary_10_1016_j_hipert_2022_05_008 crossref_primary_10_1055_a_2096_5114 crossref_primary_10_1093_aje_kwad208 crossref_primary_10_1097_AOG_0000000000005943 crossref_primary_10_3389_fmed_2025_1526406 crossref_primary_10_1093_eurjpc_zwaf435 crossref_primary_10_3390_jcdd9020055 crossref_primary_10_1016_j_ajogmf_2023_101131 crossref_primary_10_1161_HYPERTENSIONAHA_122_18730 crossref_primary_10_3390_nu17030444 crossref_primary_10_1016_j_jacc_2022_03_381 crossref_primary_10_1161_CIRCRESAHA_123_322001 crossref_primary_10_1111_1471_0528_17454 crossref_primary_10_1016_j_jacc_2022_03_383 crossref_primary_10_1136_heartjnl_2021_319606 crossref_primary_10_1007_s11886_025_02224_9 crossref_primary_10_1038_s44294_024_00040_0 crossref_primary_10_1097_HCO_0000000000001099 crossref_primary_10_3389_fpubh_2022_940335 crossref_primary_10_1007_s11886_025_02247_2 crossref_primary_10_1016_j_ejphar_2024_177031 crossref_primary_10_1186_s12916_023_03223_9 crossref_primary_10_1097_AOG_0000000000004722 crossref_primary_10_1007_s11886_023_01928_0 crossref_primary_10_1161_CIRCOUTCOMES_124_011442 crossref_primary_10_1093_eurheartj_ehad166 crossref_primary_10_1016_j_asjsur_2025_01_076 crossref_primary_10_1111_jog_16183 crossref_primary_10_1001_jamanetworkopen_2022_29716 crossref_primary_10_1038_s41598_024_57858_6 crossref_primary_10_1136_bjsports_2024_108483 crossref_primary_10_1002_ijgo_14540 crossref_primary_10_1161_STROKEAHA_123_044176 crossref_primary_10_1016_j_ajpc_2025_101000 crossref_primary_10_1161_HYPERTENSIONAHA_125_24649 crossref_primary_10_1016_j_recesp_2025_01_015 crossref_primary_10_2196_65611 crossref_primary_10_3390_nu17162578 crossref_primary_10_1161_JAHA_125_041100 crossref_primary_10_1161_CIRCRESAHA_121_319895 crossref_primary_10_1089_jwh_2024_1048 crossref_primary_10_1093_eurheartj_ehab737 crossref_primary_10_1186_s12933_024_02416_7 crossref_primary_10_1007_s40615_023_01671_w crossref_primary_10_1161_HYPERTENSIONAHA_124_24544 crossref_primary_10_1016_j_jacadv_2025_102088 crossref_primary_10_1093_eurjpc_zwae240 crossref_primary_10_1016_j_bbadis_2024_167539 crossref_primary_10_1016_j_ajog_2023_07_030 crossref_primary_10_1161_CIRCOUTCOMES_123_010842 crossref_primary_10_1002_pmf2_70092 crossref_primary_10_1093_nutrit_nuae026 crossref_primary_10_2147_IJWH_S399085 crossref_primary_10_1007_s10995_022_03483_6 crossref_primary_10_1016_j_bpa_2024_10_001 crossref_primary_10_1161_STROKEAHA_123_043052 crossref_primary_10_1001_jamacardio_2025_1887 crossref_primary_10_1089_jwh_2023_0750 crossref_primary_10_1089_met_2024_0182 crossref_primary_10_1161_CIRCULATIONAHA_124_070509 crossref_primary_10_1001_jamanetworkopen_2024_35136 crossref_primary_10_1111_1471_0528_17994 crossref_primary_10_1016_j_jacc_2022_05_012 crossref_primary_10_1001_jamanetworkopen_2021_40578 crossref_primary_10_1111_ppe_70060 crossref_primary_10_3390_jcdd9060179 crossref_primary_10_1002_jac5_1689 crossref_primary_10_1016_j_kint_2025_04_017 crossref_primary_10_1186_s12884_022_04578_2 crossref_primary_10_1186_s12884_024_07077_8 crossref_primary_10_1016_j_jacadv_2025_101660 crossref_primary_10_26599_1671_5411_2024_06_003 crossref_primary_10_3389_fpubh_2023_1075946 crossref_primary_10_1161_CIRCOUTCOMES_124_011666 crossref_primary_10_1161_HYPERTENSIONAHA_121_18394 crossref_primary_10_1111_nep_14387 crossref_primary_10_1186_s12884_024_06489_w crossref_primary_10_3390_jcm12134347 crossref_primary_10_1080_14779072_2023_2266355 crossref_primary_10_3390_healthcare13121361 crossref_primary_10_17816_RFD655468 crossref_primary_10_1016_j_ajogmf_2025_101706 crossref_primary_10_5888_pcd19_220059 crossref_primary_10_1016_j_jacadv_2024_101434 crossref_primary_10_1093_ajh_hpad103 crossref_primary_10_3390_biomedicines12061372 crossref_primary_10_1093_eurheartj_ehae905 crossref_primary_10_1161_CIRCRESAHA_121_319876 crossref_primary_10_1159_000538800 crossref_primary_10_1161_HYPERTENSIONAHA_123_22296 crossref_primary_10_1186_s12982_025_00634_2 crossref_primary_10_3390_healthcare13070728 crossref_primary_10_1001_jamanetworkopen_2024_51406 crossref_primary_10_1038_s41371_021_00652_y crossref_primary_10_1093_eurjpc_zwaf231 crossref_primary_10_3390_medicina59091547 crossref_primary_10_1001_jamahealthforum_2024_2538 crossref_primary_10_1007_s00404_024_07751_4 crossref_primary_10_1161_ATVBAHA_123_320474 crossref_primary_10_1161_JAHA_123_030452 crossref_primary_10_1007_s10554_024_03211_x crossref_primary_10_1016_j_ahj_2024_12_001 crossref_primary_10_3389_fcvm_2022_897771 crossref_primary_10_1016_j_ahj_2024_12_002 crossref_primary_10_1089_jwh_2022_0322 crossref_primary_10_1007_s12170_022_00706_x crossref_primary_10_1210_clinem_dgac346 crossref_primary_10_1161_JAHA_121_024776 crossref_primary_10_1002_ijgo_70185 crossref_primary_10_1007_s11897_024_00657_x crossref_primary_10_1161_HYPERTENSIONAHA_124_24569 crossref_primary_10_1001_jamanetworkopen_2023_50424 crossref_primary_10_1007_s13669_023_00356_9 crossref_primary_10_1016_j_cjca_2021_09_023 crossref_primary_10_1080_15376516_2024_2307975 crossref_primary_10_3389_fcvm_2022_890108 crossref_primary_10_1016_j_cmet_2024_02_016 crossref_primary_10_1016_j_puhe_2024_04_028 crossref_primary_10_1016_j_ajogmf_2022_100608 crossref_primary_10_1016_j_ijcard_2024_132745 crossref_primary_10_1186_s13293_025_00725_4 crossref_primary_10_1016_j_maturitas_2022_10_003 crossref_primary_10_1093_humrep_deae118 crossref_primary_10_1016_j_hipert_2024_07_007 crossref_primary_10_1016_j_pcad_2024_05_003 crossref_primary_10_1097_HJH_0000000000003739 crossref_primary_10_1016_j_rpth_2024_102331 crossref_primary_10_1161_CIR_0000000000001145 crossref_primary_10_1161_CIRCOUTCOMES_124_011643 crossref_primary_10_1161_HYPERTENSIONAHA_122_20448 crossref_primary_10_1093_eurjpc_zwae006 crossref_primary_10_1186_s12967_022_03578_2 crossref_primary_10_3390_jcm14113860 crossref_primary_10_1097_AOG_0000000000005571 crossref_primary_10_1016_j_jacc_2022_03_335 crossref_primary_10_1016_j_jacc_2022_03_334 crossref_primary_10_1016_j_jchf_2022_12_013 crossref_primary_10_1080_13697137_2023_2282689 crossref_primary_10_3389_fcvm_2024_1352675 crossref_primary_10_1016_j_medcle_2022_02_014 crossref_primary_10_1016_j_atherosclerosis_2023_117269 crossref_primary_10_1016_j_jacc_2022_04_009 crossref_primary_10_1161_HCQ_0000000000000117 crossref_primary_10_17116_profmed20242703198 crossref_primary_10_3390_nu15153294 crossref_primary_10_1371_journal_pone_0296244 crossref_primary_10_1161_HCQ_0000000000000112 crossref_primary_10_1001_jamanetworkopen_2022_43618 crossref_primary_10_1186_s12933_025_02858_7 crossref_primary_10_1001_jama_2021_23870 crossref_primary_10_1002_uog_23745 crossref_primary_10_1038_s44294_025_00095_7 crossref_primary_10_1186_s12884_025_07779_7 crossref_primary_10_1093_eurheartj_ehae889 crossref_primary_10_1161_JAHA_123_029848 crossref_primary_10_1111_ppe_70023 crossref_primary_10_1016_j_pmr_2024_11_001 crossref_primary_10_1161_JAHA_122_027707 crossref_primary_10_1111_dme_15516 crossref_primary_10_3390_ijms24055030 crossref_primary_10_1093_ehjopen_oeac065 crossref_primary_10_1161_CIR_0000000000001000 crossref_primary_10_1016_j_arteri_2024_08_005 crossref_primary_10_1016_j_jacc_2021_07_066 crossref_primary_10_1212_CON_0000000000001237 crossref_primary_10_1016_j_bpobgyn_2023_102435 crossref_primary_10_1016_j_ecoenv_2025_118768 crossref_primary_10_1097_HCO_0000000000001035 crossref_primary_10_1111_ppe_12929 crossref_primary_10_1097_HJH_0000000000003477 crossref_primary_10_1161_JAHA_122_027930 crossref_primary_10_1007_s11606_021_07030_x crossref_primary_10_1097_HCO_0000000000001033 crossref_primary_10_1016_j_diabres_2023_110998 crossref_primary_10_1161_HYPERTENSIONAHA_122_20628 crossref_primary_10_1161_HYPERTENSIONAHA_124_22695 crossref_primary_10_1089_jwh_2024_0285 crossref_primary_10_1186_s12933_024_02131_3 crossref_primary_10_1080_13697137_2023_2259793 crossref_primary_10_1161_CIR_0000000000001123 crossref_primary_10_1161_CIR_0000000000001124 crossref_primary_10_1038_s41440_022_00853_z crossref_primary_10_1186_s12884_025_08156_0 crossref_primary_10_1186_s12889_023_17119_z crossref_primary_10_1210_clinem_dgad600 crossref_primary_10_1016_j_jacadv_2022_100142 crossref_primary_10_1097_AOG_0000000000005672 crossref_primary_10_1007_s10995_023_03661_0 crossref_primary_10_1097_HJH_0000000000003480 crossref_primary_10_1161_HYPERTENSIONAHA_124_23303 crossref_primary_10_36660_abc_20230433 crossref_primary_10_1016_j_ajogmf_2024_101366 crossref_primary_10_14412_2074_2711_2025_3_127_134 crossref_primary_10_1016_j_nwh_2024_05_005 crossref_primary_10_2337_dc22_0401 crossref_primary_10_1186_s12905_022_02125_x crossref_primary_10_1016_j_ajog_2024_04_008 crossref_primary_10_1016_j_ajogmf_2024_101371 crossref_primary_10_1016_j_cjca_2021_08_011 crossref_primary_10_1097_GRF_0000000000000724 crossref_primary_10_1186_s12916_024_03489_7 crossref_primary_10_1210_clinem_dgad755 crossref_primary_10_1016_j_ahjo_2025_100558 crossref_primary_10_1136_bmjopen_2024_084212 crossref_primary_10_3390_healthcare12131361 crossref_primary_10_1016_j_yjmcc_2024_07_002 crossref_primary_10_1161_CIR_0000000000001212 crossref_primary_10_1161_JAHA_124_039239 crossref_primary_10_1016_j_cjca_2021_08_007 crossref_primary_10_1161_CIRCULATIONAHA_123_065827 crossref_primary_10_1097_AOG_0000000000004453 crossref_primary_10_1161_CIRCRESAHA_123_322762 crossref_primary_10_1016_j_ijcrp_2024_200260 crossref_primary_10_3389_fmed_2023_1144170 crossref_primary_10_3389_fendo_2024_1293292 crossref_primary_10_1001_jamanetworkopen_2022_48165 crossref_primary_10_1016_j_fertnstert_2022_07_002 crossref_primary_10_1111_1471_0528_17970 crossref_primary_10_1186_s12916_023_02794_x crossref_primary_10_1016_j_fertnstert_2023_09_012 crossref_primary_10_1136_heartjnl_2021_320684 crossref_primary_10_1007_s00129_024_05261_7 crossref_primary_10_1007_s11883_022_01026_6 crossref_primary_10_1186_s12884_023_05605_6 crossref_primary_10_1007_s11883_022_01065_z crossref_primary_10_1016_S0140_6736_22_02610_1 crossref_primary_10_1080_28355245_2025_2553042 crossref_primary_10_1093_aje_kwad056 crossref_primary_10_1161_HYPERTENSIONAHA_121_18451 crossref_primary_10_1093_eurjpc_zwac307 crossref_primary_10_1111_ppe_13119 crossref_primary_10_1016_j_jacc_2025_02_033 crossref_primary_10_1016_j_jchf_2023_02_019 crossref_primary_10_1089_jwh_2024_0148 crossref_primary_10_1007_s00438_024_02208_4 crossref_primary_10_1002_ejhf_3301 crossref_primary_10_1161_HYPERTENSIONAHA_124_22919 crossref_primary_10_1093_eurheartj_ehaf193 crossref_primary_10_1186_s12889_023_17087_4 crossref_primary_10_1016_j_pcad_2022_11_001 crossref_primary_10_1017_S0007114524000746 crossref_primary_10_1097_HCO_0000000000001122 crossref_primary_10_1016_j_ajcnut_2025_04_034 crossref_primary_10_1017_S0029665124000181 crossref_primary_10_3389_fcvm_2022_1000298 crossref_primary_10_1007_s11886_022_01830_1 crossref_primary_10_1161_CIR_0000000000001316 crossref_primary_10_1210_endocr_bqad060 crossref_primary_10_1016_j_ajog_2024_11_018 crossref_primary_10_1089_whr_2023_0039 crossref_primary_10_1016_j_amepre_2021_10_007 crossref_primary_10_1016_j_cjca_2024_02_010 crossref_primary_10_1016_j_jacc_2021_09_1361 crossref_primary_10_1016_j_jacc_2024_05_016 crossref_primary_10_2147_IJWH_S328441 crossref_primary_10_1016_j_amepre_2024_12_013 crossref_primary_10_1080_14779072_2021_1937127 crossref_primary_10_1136_heartjnl_2024_325355 crossref_primary_10_1016_j_cjca_2022_09_004 crossref_primary_10_1161_STR_0000000000000475 crossref_primary_10_1016_j_jacc_2024_02_039 crossref_primary_10_1136_heartjnl_2022_321606 crossref_primary_10_1136_heartjnl_2024_325493 crossref_primary_10_1161_CIR_0000000000001209 crossref_primary_10_1016_j_amepre_2023_10_016 crossref_primary_10_1097_AOG_0000000000005634 crossref_primary_10_1007_s40618_023_02233_x crossref_primary_10_1016_j_puhe_2024_02_016 crossref_primary_10_1001_jamanetworkopen_2024_26394 crossref_primary_10_1161_HYPERTENSIONAHA_122_19275 crossref_primary_10_1161_HYPERTENSIONAHA_122_19399 crossref_primary_10_1016_j_tjnut_2023_03_006 crossref_primary_10_1097_AOG_0000000000005990 crossref_primary_10_1161_JAHA_121_022746 crossref_primary_10_3390_ijerph21121628 crossref_primary_10_1038_s44294_024_00007_1 crossref_primary_10_1080_03630242_2024_2349572 crossref_primary_10_1016_j_ajogmf_2024_101561 crossref_primary_10_1016_j_maturitas_2023_04_001 crossref_primary_10_1016_j_jacc_2025_03_495 crossref_primary_10_1136_bmj_2022_072112 crossref_primary_10_1093_aje_kwae219 crossref_primary_10_1186_s12933_025_02811_8 crossref_primary_10_3390_jcm10204664 crossref_primary_10_1016_j_maturitas_2022_06_012 crossref_primary_10_1016_j_ahj_2021_08_019 crossref_primary_10_1016_j_jacadv_2024_101295 crossref_primary_10_1016_j_ajog_2024_05_007 crossref_primary_10_3390_ijerph21010089 crossref_primary_10_1001_jama_2023_11210 crossref_primary_10_1007_s10654_024_01135_3 crossref_primary_10_1007_s15034_022_3817_2 crossref_primary_10_1007_s11606_021_07149_x crossref_primary_10_1371_journal_pone_0298927 crossref_primary_10_1007_s12170_023_00732_3 crossref_primary_10_1007_s12016_021_08907_9 crossref_primary_10_1016_j_ajogmf_2024_101339 crossref_primary_10_1016_S0140_6736_23_01517_9 crossref_primary_10_1161_HYPERTENSIONAHA_123_22577 crossref_primary_10_1016_j_jacl_2022_04_007 crossref_primary_10_1016_j_amjms_2023_09_001 crossref_primary_10_1089_jwh_2023_0930 crossref_primary_10_1161_CIRCRESAHA_121_319915 crossref_primary_10_1161_JAHA_122_028133 crossref_primary_10_3390_ijerph192416827 crossref_primary_10_1016_j_ajogmf_2024_101334 crossref_primary_10_3390_antiox12020463 crossref_primary_10_1089_whr_2022_0066 crossref_primary_10_3390_antiox12020341 crossref_primary_10_3390_nu16060781 crossref_primary_10_1007_s13669_024_00411_z crossref_primary_10_1136_bmj_2023_075031 crossref_primary_10_1152_ajpheart_00763_2023 crossref_primary_10_1016_j_xagr_2025_100519 crossref_primary_10_1161_CIR_0000000000001303 crossref_primary_10_1007_s11886_023_01961_z crossref_primary_10_1001_jamainternmed_2023_4401 crossref_primary_10_1161_CIRCULATIONAHA_121_058054 crossref_primary_10_1007_s00508_023_02313_1 crossref_primary_10_1001_jamanetworkopen_2021_38071 crossref_primary_10_1016_j_artere_2025_100736 crossref_primary_10_2478_amb_2025_00067 crossref_primary_10_1016_S2213_8587_22_00076_6 crossref_primary_10_1111_1471_0528_17486 crossref_primary_10_1016_j_jbc_2023_102964
ContentType	Journal Article
CorporateAuthor	American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council
CorporateAuthor_xml	– name: American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1161/CIR.0000000000000961
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1524-4539
ExternalDocumentID	33779213
Genre	Journal Article
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GroupedDBID	--- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 AAFWJ ABPXF ADKSD ADSXY
ID	FETCH-LOGICAL-c4185-41efd77d5ed9a8d531a79e07c1032d4017e475cf3d4703a7760fa23f1326fecc2
IEDL.DBID	7X8
ISICitedReferencesCount	439
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003017-202105040-00015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1524-4539
IngestDate	Mon Sep 08 12:33:49 EDT 2025 Thu Apr 03 07:03:43 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	18
Keywords	primary prevention risk factors pregnancy complications cardiovascular diseases pregnancy AHA Scientific Statements
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4185-41efd77d5ed9a8d531a79e07c1032d4017e475cf3d4703a7760fa23f1326fecc2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	33779213
PQID	2506508375
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2506508375 pubmed_primary_33779213
PublicationCentury	2000
PublicationDate	2021-05-04 20210504
PublicationDateYYYYMMDD	2021-05-04
PublicationDate_xml	– month: 05 year: 2021 text: 2021-05-04 day: 04
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Circulation (New York, N.Y.)
PublicationTitleAlternate	Circulation
PublicationYear	2021
SSID	ssj0006375
Score	2.7207565
SecondaryResourceType	review_article
Snippet	This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes,...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	e902
SubjectTerms	American Heart Association - organization & administration Cardiovascular Diseases - prevention & control Female Humans Pregnancy Pregnancy Outcome - epidemiology Risk Factors United States
Title	Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association
URI	https://www.ncbi.nlm.nih.gov/pubmed/33779213 https://www.proquest.com/docview/2506508375
Volume	143
WOSCitedRecordID	wos00003017-202105040-00015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF58IV58vx-MIN6CTXaTzfYipVoUtBZR6a2k2V0p4qY2rdDf5p9zdpOgHgTBHHILCezst9_MfPmGkBNrqaIpU16gfe0x0WdeHEpMXIWKmFKiJpzK9-mGt9txtys6ZcEtL2WVFSY6oJZZamvkZ3hUWzJBeXg-fPPs1CjbXS1HaMySeYpUxkq6ePfLLTyizmgXjyjmsZCK8tc5JDlnzev7wrqwukTk_04y3WHTWvnvZ66S5ZJmQqOIizUyo8w62WgYTLFfp3AKTvjpKurrZPG27K9vkA83nzlX0BmpZ2vFMYW7yRjfrHJIjITmD_UqXBTdHbgf5C91eHResHA3tJR-YpxVKyAn_u2pyj0qMzAw4EZp1qEBDm2cggkcE7blS2iNsldArgpVhwmucIuO4Vt0bZLH1uVD88orxzt4qXXM8ZivtORchkqKJJYIBgkXqsZT6_EnMe_jivEw1VQyhKWE86imk4BqzJ8jjZEXbJE5kxm1QyC2vnKiH4VhgsivnIudloGf1nTf13G6S46r1erh9rE9kcSobJL3vtZrl2wXS94bFj4fPWrNGAOf7v3h6X2yFFi1i5VCsgMyrxE81CFZSN_Hg3x05OIS7-3O7SfW5O6M
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adverse+Pregnancy+Outcomes+and+Cardiovascular+Disease+Risk%3A+Unique+Opportunities+for+Cardiovascular+Disease+Prevention+in+Women%3A+A+Scientific+Statement+From+the+American+Heart+Association&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Parikh%2C+Nisha+I&rft.au=Gonzalez%2C+Juan+M&rft.au=Anderson%2C+Cheryl+A+M&rft.au=Judd%2C+Suzanne+E&rft.date=2021-05-04&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=143&rft.issue=18&rft.spage=e902&rft_id=info:doi/10.1161%2FCIR.0000000000000961&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon